Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

3(42.9%)

N/A

2(28.6%)

Phase 1

1(14.3%)

Phase 3

1(14.3%)

7Total

Phase 2(3)

N/A(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04337450Phase 2Active Not Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Role: collaborator

NCT05993767Phase 2Completed

UNIVERSAL 1: Pharmacokinetic Study of a Novel DTG/FTC/TAF Dose Ratio for Children

Role: collaborator

NCT00007423Phase 1Completed

Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda

Role: collaborator

NCT04768179Phase 2Unknown

Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients

Role: collaborator

NCT04542941Not ApplicableCompleted

Assessment of Safety and Efficacy of CCP

Role: collaborator

NCT03596996Not ApplicableCompleted

Optimizing Iron Status While Minimizing Morbidity in HIV-infected Ugandan Children

Role: collaborator

NCT00573313Phase 3Completed

Effects of SAMe in Patients With Alcoholic Liver Disease

Role: collaborator

NCT00505830Unknown

Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome: AQ, EQ and SQ

Role: collaborator

All 8 trials loaded